Treatments for macular degeneration in the UK: offering laser treatment for extrafoveal neovascular membrane. For subfoveal or juxtafoveal they offer PDT for predominantly classic lesions, and then the anti-VEGF treatments. Just as in the US, Lucentis is approved but Avastin is available off-label for some patients (based in financial constraints). Macugen is not considered cost-effective. Until NICE approved the use of Lucentis, many (Read more...)
Winfried Amoaku, MD Outlines Retina Treatments in the UK
In an interview with retina specialist Sophie Bakri, MD of the Mayo Clinic, Dr. Winfried Amoaku discusses ophthalmology in the context of the UK's National Health System.